Up to three development programs per year leading to a potential total deal value exceeding $1…
Continue ReadingTag: Therapeutics
Small-Cap Grace Therapeutics Touts Positive Data From Brain Hemorrhage Study – Grace Therapeutics (NASDAQ:GRCE)
On Monday, Grace Therapeutics, Inc. GRCE, formerly b, announced topline data from its Phase 3 STRIVE-ON…
Continue Reading
Sling Therapeutics to Announce Topline Results from Phase 2b/3 LIDS Clinical Trial of Oral Small Molecule Linsitinib in Patients with Thyroid Eye Disease at the 43rd Annual J.P. Morgan Healthcare Conference
ANN ARBOR, Mich., Jan. 13, 2025 /PRNewswire/ — Sling Therapeutics, Inc., a late-stage biopharmaceutical company focused…
Continue Reading